Novel Cell-Based Assays for Screening Modulators of Autophagic Vacuoles, Autophagosomes and Aggregated Protein Cargo
Wayne Patton, Enzo Life Sciences, Chief Scientific Officer, speaking at Probe Discovery 2010.
A Roadmap for Successful Probe Discovery in an Academic Setting: The KU Experience
Rathnam Chaguturu, University of Kansas, Director, speaking at Probe Discovery 2010.
True and False HTS Leads for Probe Discovery
Cristian Bologa, University of New Mexico, Associate Professor, speaking at Probe Discovery 2010.
The Foundation of the NIH (FNIH) Biomarkers Consortium Builds Consensus Through Public Private Partnerships
Maria Vassileva, Scientific Program Manager, Foundation for the National Institutes of Health, speaking at European Biomarkers Summit 2009
Accelerating Translational Proteomics Studies with Multiple Reaction Monitoring
Daniel Chelsky, Chief Scientific Officer, Caprion Proteomics Inc., speaking at European Biomarkers Summit 2009
Quantification of Specific Molecular Binding by Magnetorelaxometry
Dietmar Eberbeck, Scientist, Physikalisch-Technische-Bundesanstalt, speaking at European Biomarkers Summit 2009
Industry Snapshot: Cancer Personalized Medicine Market Landscape
Enal Razvi, Biotechnology Analyst, Select Biosciences, speaking at European Biomarkers Summit 2009
In Search of Biomarkers, Mass Spectrometry as a Tool for Discovery
In this webinar, hear from experts in the field about the challenges and solutions associated with the search for biomarkers and promising analytical solutions to address them.
Genetic Polymorphisms Associated to Adverse Reactions to 5-FU or Capecitabine in Colorectal Cancer Patients
Luis Lopez-Fernandez, Lab Director, Hospital General Universitario Gregorio Marañon, speaking at European Biomarkers Summit 2009